Ruth McKernan joined SV in 2018 as a Venture Partner. She co-founded the Dementia Discovery Fund formed companies Loqus23, AstronauTx and Cumulus as well as supporting the formation of Alchemab, an SV formed company.
DDF Portfolio Board Roles
Chair of AstronauTx, Cumulus
Ruth has over 25 years in the Pharma Industry at Merck and Pfizer, leading several Research Sites in the UK and US during her career. She has set up new Research Units, including Pfizer Regenerative Medicine and Neusentis, initiated multiple neuroscience partnerships, acquisitions and spinouts and played an active role in taking more than 10 compounds into the clinic. Immediately prior to joining SV, she spent 3 years as CEO of the UK Government’s Innovation agency, InnovateUK, supporting the UK’s Industrial Strategy with responsibility for investing an annual budget of £1Bn into Technology centres and SMEs.
Outside of SV, Ruth is a trustee for Alzheimer’s Research UK and Chair of the UK’s BioIndustry Association. She is an enthusiast for innovation and entrepreneurship, sitting on multiple innovation and translation boards including the Academy of Engineering and the Francis Crick Institute. Ruth was made a Commander of the British Empire for services to business and innovation in 2013 and elected a Fellow of the Academy of Medical Sciences in 2015. In her spare time Ruth is an award winning science writer, avid gardener and spokesperson for Women in Innovation.
Ruth Has a BSc in Pharmacology and Biochemistry, a PhD in neuroscience and Honorary DSc from two Universities.